This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Expedia, Starbucks: New Targets, Estimates

Stocks in this article: KLAC IPG HOT GTE EXPE CELG SBUX

Also see: Vertex, AIG: Analysts' New Ratings

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK ( TheStreet) -- STOCK COMMENTS / EPS CHANGES

Automatic Data Processing (ADP) estimates, target adjusted at Citigroup. Shares of ADP now seen reaching $58. Estimates adjusted through 2013. Mixed quarter, but strong FY12 guidance.

Celgene (CELG) estimates, target increased at UBS. Shares of CELG now seen reaching $71. Estimates also increased on strong beat and raise in 2Q. Buy rating.

Cerner (CERN) estimates, target increased at Goldman. CERN estimates were raised through 2013. Company is seeing higher bookings and is expanding margins. Buy rating and new $80 price target.

Cerner estimates, target increased at UBS. Shares of CERN now seen reaching $65. Estimates also increased on large bookings and faster growth forecasts. Neutral rating.

CME Group (CME) estimates, target higher at UBS. Shares of CME now seen reaching $325. Estimates also raised on strong 2Q and attractive growth profile. Buy rating.

Expedia (EXPE) estimates, target raised at Citigroup. Shares of EXPE now seen reaching $36, according to Citigroup. Estimates also increased on solid 2Q and stable US market share. Buy rating.

Expedia estimates, target increased at UBS. Shares of EXPE now seen reaching $33, UBS said. Estimates also increased on Q2 beat and conservative guidance. Neutral rating.

Graco (GGG) estimates, target reduced at Goldman. Shares of GGG now seen reaching $47.50, according to Goldman Sachs. Estimates also cut, as the company is realizing a slower demand recovery. Sell rating.

Goodyear (GT) estimates raised at Citigroup through 2012. Q2 beat and stronger price/mix. Maintain $22 price target and Buy rating.

Starwood Hotels (HOT) estimates lowered at UBS. HOT estimates lowered through 2012. Valuation call. Maintain $70 price target and Buy rating.

Interpublic (IPG) estimates, target lowered at Goldman. IPG estimates were cut through 2013. Lower sales are cutting into margins. Neutral rating and new $12 price target.

KLA-Tencor (KLAC) estimates lowered at UBS through 2012. Expect 2H weakness. Maintain $49.50 price target and Buy rating.



Life Technologies (LIEF) estimates, target lowered at UBS. Shares of LIFE now seen reaching $55. Estimates also lowered on organic revenue and EPS misses. Buy rating.

MetLife (MET) estimates raised at UBS through 2011. International results solid, especially top line trends. Maintain $60 price target and Buy rating.

Motorola (MMI) estimates, target cut at UBS. Shares of MMI now seen reaching $31, according to UBS. Estimates also lowered as new product launches need to "stick." Buy rating.

Noble Energy (NBL) numbers raised at Goldman. Shares of NBL now seen reaching $126, according to Goldman Sachs. Estimates also increased, given higher production and free cash flow results. Buy rating.

NetLogic Microsystem (NETL) estimates, target lowered at UBS. Shares of NETL now seen reaching $44. Estimates also lowered as soft macro weighs on growth outlook. Buy rating.

Potash (POT) estimates, target boosted at Goldman. Shares of POT now seen reaching $67. Estimates also upped, to match the company's new guidance. Buy rating.

Sprint Nextel (S) estimates, target cut at UBS. Shares of S now seen reaching $5, according to UBS. Estimates also lowered on weak postpaid adds and margins in 2Q. Neutral rating.

Starbucks (SBUX) estimates, target raised at UBS. Shares of SBUX now seen reaching $47. Estimates also raised on higher medium term revenue and free cash flow. Buy rating.

Strayer (STRA) estimates, target reduced at Goldman. Shares of STRA now seen reaching $134, according to Goldman Sachs. Estimates also lowered, given lower enrollment rates. Neutral rating.

Teradyne (TER) estimates lowered at UBS through 2011, UBS said. Working through a normal downcycle. Maintain $16 price target and Neutral rating.



End of report.

This article was written by a staff member of TheStreet.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,778.15 +421.28 2.43%
S&P 500 2,061.23 +48.34 2.40%
NASDAQ 4,748.3960 +104.0840 2.24%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs